Non-Invasive Prenatal Testing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global non-invasive prenatal testing looks promising with opportunities in the in trisomy, aneuploidy, and microdeletion. The global non-invasive prenatal testing market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global non-invasive prenatal testing market report, please download the report brochure.
non-invasive prenatal testing
In this market, trisomy is the largest application segment of non-invasive prenatal testing, diagnostic laboratories is the largest end user. Growth in various segments of the non-invasive prenatal testing market are given below:
non-invasive prenatal testing
The study includes trends and forecast for the global non-invasive prenatal testing market by by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ConsumablesReagentsUltrasoundNGSPCRMicroarray
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
cfDNABiochemical Markers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
TrisomyAneuploidyMicrodeletion
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsDiagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the non-invasive prenatal testing companies profiled in this report include Illumina, Thermo Fisher Scientific, GE Healthcare, BGI, Agilent Technologies, F. Hoffmann-La Roche, PerkinElmer, Laboratory Corporation of America Holdings, Natera, and Yourgene Health.
Lucintel forecasts that the trisomy will remain the largest application segment over the forecast period due to factors such as increasing maternal age and the rising incidence of chromosomal abnormalities.
Within this market, diagnostic laboratories will remain the largest end user segment over the forecast period due to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
Asia-Pacific will remain the fastest grwoing region over the forecast period due to developing healthcare infrastructure, rising awareness of programs & conferences, and rising focus of prominent players on expanding their presence in this region.
Features of the Global Non-Invasive Prenatal Testing Market
Market Size Estimates: Global non-invasive prenatal testing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global non-invasive prenatal testing market size by various segments, such as product, method, application, and end user in terms of value.Regional Analysis: Global non-invasive prenatal testing market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, method, application, end user, and region for the global non-invasive prenatal testing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global non-invasive prenatal testing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global global non-invasive prenatal testing market by product (consumables, reagents, ultrasound, NGS, PCR, and microarray), method (cfDNA and biochemical markers), application (trisomy, aneuploidy, and microdeletion), end user (hospitals and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global non-invasive prenatal testing market?
Q.5 What are the business risks and threats to the global non-invasive prenatal testing market?
Q.6 What are the emerging trends in this non-invasive prenatal testing market and the reasons behind them?
Q.7 What are some changing demands of customers in this non-invasive prenatal testing market?
Q.8 What are the new developments in this non-invasive prenatal testing market? Which companies are leading these developments?
Q.9 Who are the major players in this non-invasive prenatal testing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this non-invasive prenatal testing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global non-invasive prenatal testing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray), Method (cfDNA and Biochemical Markers), Application (Trisomy, Aneuploidy, and Microdeletion), and End User (Hospitals and Diagnostic Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW ( Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global non-invasive prenatal testing looks promising with opportunities in the in trisomy, aneuploidy, and microdeletion. The global non-invasive prenatal testing market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global non-invasive prenatal testing market report, please download the report brochure.
non-invasive prenatal testing
In this market, trisomy is the largest application segment of non-invasive prenatal testing, diagnostic laboratories is the largest end user. Growth in various segments of the non-invasive prenatal testing market are given below:
non-invasive prenatal testing
The study includes trends and forecast for the global non-invasive prenatal testing market by by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ConsumablesReagentsUltrasoundNGSPCRMicroarray
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
cfDNABiochemical Markers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
TrisomyAneuploidyMicrodeletion
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsDiagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the non-invasive prenatal testing companies profiled in this report include Illumina, Thermo Fisher Scientific, GE Healthcare, BGI, Agilent Technologies, F. Hoffmann-La Roche, PerkinElmer, Laboratory Corporation of America Holdings, Natera, and Yourgene Health.
Lucintel forecasts that the trisomy will remain the largest application segment over the forecast period due to factors such as increasing maternal age and the rising incidence of chromosomal abnormalities.
Within this market, diagnostic laboratories will remain the largest end user segment over the forecast period due to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
Asia-Pacific will remain the fastest grwoing region over the forecast period due to developing healthcare infrastructure, rising awareness of programs & conferences, and rising focus of prominent players on expanding their presence in this region.
Features of the Global Non-Invasive Prenatal Testing Market
Market Size Estimates: Global non-invasive prenatal testing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global non-invasive prenatal testing market size by various segments, such as product, method, application, and end user in terms of value.Regional Analysis: Global non-invasive prenatal testing market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, method, application, end user, and region for the global non-invasive prenatal testing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global non-invasive prenatal testing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global global non-invasive prenatal testing market by product (consumables, reagents, ultrasound, NGS, PCR, and microarray), method (cfDNA and biochemical markers), application (trisomy, aneuploidy, and microdeletion), end user (hospitals and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global non-invasive prenatal testing market?
Q.5 What are the business risks and threats to the global non-invasive prenatal testing market?
Q.6 What are the emerging trends in this non-invasive prenatal testing market and the reasons behind them?
Q.7 What are some changing demands of customers in this non-invasive prenatal testing market?
Q.8 What are the new developments in this non-invasive prenatal testing market? Which companies are leading these developments?
Q.9 Who are the major players in this non-invasive prenatal testing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this non-invasive prenatal testing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global non-invasive prenatal testing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray), Method (cfDNA and Biochemical Markers), Application (Trisomy, Aneuploidy, and Microdeletion), and End User (Hospitals and Diagnostic Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW ( Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Non-Invasive Prenatal Testing Market Trends and Forecast
3.3: Global Non-Invasive Prenatal Testing Market by Product
3.3.1: Consumables
3.3.2: Reagents
3.3.3: Ultrasound
3.3.4: NGS
3.3.5: PCR
3.3.6: Microarray
3.4: Global Non-Invasive Prenatal Testing Market by Method
3.4.1: cfDNA
3.4.2: Biochemical Markers
3.5: Global Non-Invasive Prenatal Testing Market by Application
3.5.1: Trisomy
3.5.2: Aneuploidy
3.5.3: Microdeletion
3.6: Global Non-Invasive Prenatal Testing Market by End User
3.6.1: Hospitals
3.6.2: Diagnostic Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Non-Invasive Prenatal Testing Market by Region
4.2: North American Non-Invasive Prenatal Testing Market
4.2.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.2.2: Market by Method: cfDNA and Biochemical Markers
4.2.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.2.4: Market by End User: Hospitals and Diagnostic Laboratories
4.2.5: The United States Non-Invasive Prenatal Testing Market
4.2.6: The Canadian Non-Invasive Prenatal Testing Market
4.2.7: The Mexican Non-Invasive Prenatal Testing Market
4.3: European Non-Invasive Prenatal Testing Market
4.3.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.3.2: Market by Method: cfDNA and Biochemical Markers
4.3.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.3.4: Market by End User: Hospitals and Diagnostic Laboratories
4.3.5: The United Kingdom Non-Invasive Prenatal Testing Market
4.3.6: The Spanish Non-Invasive Prenatal Testing Market
4.3.7: The German Non-Invasive Prenatal Testing Market
4.3.8: The French Non-Invasive Prenatal Testing Market
4.4: APAC Non-Invasive Prenatal Testing Market
4.4.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.4.2: Market by Method: cfDNA and Biochemical Markers
4.4.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.4.4: Market by End User: Hospitals and Diagnostic Laboratories
4.4.5: The Chinese Non-Invasive Prenatal Testing Market
4.4.6: The Indian Non-Invasive Prenatal Testing Market
4.4.7: The Japanese Non-Invasive Prenatal Testing Market
4.5: ROW Non-Invasive Prenatal Testing Market
4.5.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.5.2: Market by Method: cfDNA and Biochemical Markers
4.5.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.5.4: Market by End User: Hospitals and Diagnostic Laboratories
4.5.5: Brazilian Non-Invasive Prenatal Testing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Product
7.1.2: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Method
7.1.3: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Application
7.1.4: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by End User
7.1.5: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Region
7.2: Emerging Trends in the Global Non-Invasive Prenatal Testing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Non-Invasive Prenatal Testing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Non-Invasive Prenatal Testing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Illumina
8.2: Therm Fisher Scientific
8.3: GE Healthcare
8.4: BGI
8.5: Agilent Technologies
8.6: F. Hoffmann-La Roche
8.7: PerkinElmer
8.8: Laboratory Corporation of America Holdings
8.9: Natera
8.10: Yourgene Health
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Non-Invasive Prenatal Testing Market Trends and Forecast
3.3: Global Non-Invasive Prenatal Testing Market by Product
3.3.1: Consumables
3.3.2: Reagents
3.3.3: Ultrasound
3.3.4: NGS
3.3.5: PCR
3.3.6: Microarray
3.4: Global Non-Invasive Prenatal Testing Market by Method
3.4.1: cfDNA
3.4.2: Biochemical Markers
3.5: Global Non-Invasive Prenatal Testing Market by Application
3.5.1: Trisomy
3.5.2: Aneuploidy
3.5.3: Microdeletion
3.6: Global Non-Invasive Prenatal Testing Market by End User
3.6.1: Hospitals
3.6.2: Diagnostic Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Non-Invasive Prenatal Testing Market by Region
4.2: North American Non-Invasive Prenatal Testing Market
4.2.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.2.2: Market by Method: cfDNA and Biochemical Markers
4.2.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.2.4: Market by End User: Hospitals and Diagnostic Laboratories
4.2.5: The United States Non-Invasive Prenatal Testing Market
4.2.6: The Canadian Non-Invasive Prenatal Testing Market
4.2.7: The Mexican Non-Invasive Prenatal Testing Market
4.3: European Non-Invasive Prenatal Testing Market
4.3.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.3.2: Market by Method: cfDNA and Biochemical Markers
4.3.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.3.4: Market by End User: Hospitals and Diagnostic Laboratories
4.3.5: The United Kingdom Non-Invasive Prenatal Testing Market
4.3.6: The Spanish Non-Invasive Prenatal Testing Market
4.3.7: The German Non-Invasive Prenatal Testing Market
4.3.8: The French Non-Invasive Prenatal Testing Market
4.4: APAC Non-Invasive Prenatal Testing Market
4.4.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.4.2: Market by Method: cfDNA and Biochemical Markers
4.4.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.4.4: Market by End User: Hospitals and Diagnostic Laboratories
4.4.5: The Chinese Non-Invasive Prenatal Testing Market
4.4.6: The Indian Non-Invasive Prenatal Testing Market
4.4.7: The Japanese Non-Invasive Prenatal Testing Market
4.5: ROW Non-Invasive Prenatal Testing Market
4.5.1: Market by Product: Consumables, Reagents, Ultrasound, NGS, PCR, and Microarray
4.5.2: Market by Method: cfDNA and Biochemical Markers
4.5.3: Market by Application: Trisomy, Aneuploidy, and Microdeletion
4.5.4: Market by End User: Hospitals and Diagnostic Laboratories
4.5.5: Brazilian Non-Invasive Prenatal Testing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Product
7.1.2: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Method
7.1.3: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Application
7.1.4: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by End User
7.1.5: Growth Opportunities for the Global Non-Invasive Prenatal Testing Market by Region
7.2: Emerging Trends in the Global Non-Invasive Prenatal Testing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Non-Invasive Prenatal Testing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Non-Invasive Prenatal Testing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Illumina
8.2: Therm Fisher Scientific
8.3: GE Healthcare
8.4: BGI
8.5: Agilent Technologies
8.6: F. Hoffmann-La Roche
8.7: PerkinElmer
8.8: Laboratory Corporation of America Holdings
8.9: Natera
8.10: Yourgene Health
